Log in
Enquire now

List of SBIR/STTR awards granted to Guilford Pharmaceuticals, Inc.

List of SBIR/STTR awards granted to Guilford Pharmaceuticals, Inc.
List of SBIR/STTR awards granted to Great Lakes Neurotechnologies Inc.
List of SBIR/STTR awards granted to AUSTRAL ENGINEERING & SOFTWARE, INC.
List of SBIR/STTR awards granted to Sanguine Diagnostics And Therapeutics, Inc.
Investors in Zymergen
List of Ambit Biosciences patents
where
SBIR/STTR Award Recipient
is
‌
Guilford Pharmaceuticals, Inc.
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $106,742.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43DK070354-01A1
Phase I
106,742
sbir.gov/content/parp-inhibitors-acute-renal-failure-0
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $148,000.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43NS049669-01A1
Phase I
148,000
sbir.gov/content/therapeutic-utility-glutaminase-inhibitors-0
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $455,000.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43MH069123-01A1
Phase I
455,000
sbir.gov/content/immunophilin-ligands-and-age-related-cognition-0
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $161,278.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43CA103385-01A2
Phase I
161,278
sbir.gov/content/psma-ligands-targeted-cancer-radiotherapy-0
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $107,000.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43CA105849-01
Phase I
107,000
sbir.gov/content/parp-inhibitors-chemotherapy-brain-tumors-0
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $95,013.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43HL076042-01
Phase I
95,013
sbir.gov/content/parp-inhibitors-treating-cardiac-arrest-0
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $140,170.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43CA103568-01
Phase I
140,170
sbir.gov/content/psma-ligands-targeted-prostate-cancer-chemotherapy-0
‌
Guilford Pharmaceuticals, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Guilford Pharmaceuticals, Inc. for $97,500.0 USD from the U.S. Department of Health & Human Services.

‌
Guilford Pharmaceuticals, Inc.
SBIR
1R43NS046952-01A1
Phase I
97,500
sbir.gov/content/serine-racemase-inhibition-decrease-nmda-r-activation-0
8 results
0 selected
8 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →